Skip to main content
Journal of Virology logoLink to Journal of Virology
. 1992 Jul;66(7):4085–4097. doi: 10.1128/jvi.66.7.4085-4097.1992

The surface envelope protein gene region of equine infectious anemia virus is not an important determinant of tropism in vitro.

S T Perry 1, M T Flaherty 1, M J Kelley 1, D L Clabough 1, S R Tronick 1, L Coggins 1, L Whetter 1, C R Lengel 1, F Fuller 1
PMCID: PMC241211  PMID: 1318398

Abstract

Virulent, wild-type equine infectious anemia virus (EIAV) is restricted in one or more early steps in replication in equine skin fibroblast cells compared with cell culture-adapted virus, which is fully competent for replication in this cell type. We compared the sequences of wild-type EIAV and a full-length infectious proviral clone of the cell culture-adapted EIAV and found that the genomes were relatively well conserved with the exception of the envelope gene region, which showed extensive sequence differences. We therefore constructed several wild-type and cell culture-adapted virus chimeras to examine the role of the envelope gene in replication in different cell types in vitro. Unlike wild-type virus, which is restricted by an early event(s) for replication in equine dermis cells, the wild-type outer envelope gene chimeras are replication competent in this cell type. We conclude that even though there are extensive sequence differences between wild-type and cell culture-adapted viruses in the surface envelope gene region, this domain is not a determinant of the differing in vitro cell tropisms.

Full text

PDF

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Archer B. G., Crawford T. B., McGuire T. C., Frazier M. E. RNA-dependent DNA polymerase associated with equine infectious anemia virus. J Virol. 1977 Apr;22(1):16–22. doi: 10.1128/jvi.22.1.16-22.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ball J. M., Rushlow K. E., Issel C. J., Montelaro R. C. Detailed mapping of the antigenicity of the surface unit glycoprotein of equine infectious anemia virus by using synthetic peptide strategies. J Virol. 1992 Feb;66(2):732–742. doi: 10.1128/jvi.66.2.732-742.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cann A. J., Zack J. A., Go A. S., Arrigo S. J., Koyanagi Y., Green P. L., Koyanagi Y., Pang S., Chen I. S. Human immunodeficiency virus type 1 T-cell tropism is determined by events prior to provirus formation. J Virol. 1990 Oct;64(10):4735–4742. doi: 10.1128/jvi.64.10.4735-4742.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Carpenter S., Chesebro B. Change in host cell tropism associated with in vitro replication of equine infectious anemia virus. J Virol. 1989 Jun;63(6):2492–2496. doi: 10.1128/jvi.63.6.2492-2496.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Carpenter S., Evans L. H., Sevoian M., Chesebro B. Role of the host immune response in selection of equine infectious anemia virus variants. J Virol. 1987 Dec;61(12):3783–3789. doi: 10.1128/jvi.61.12.3783-3789.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Charman H. P., Bladen S., Gilden R. V., Coggins L. Equine infectious anemia virus: evidence favoring classification as a retravirus. J Virol. 1976 Sep;19(3):1073–1079. doi: 10.1128/jvi.19.3.1073-1079.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cheevers W. P., Archer B. G., Crawford T. B. Characterization of RNA from equine infectious anemia virus. J Virol. 1977 Nov;24(2):489–497. doi: 10.1128/jvi.24.2.489-497.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Chong Y. H., Ball J. M., Issel C. J., Montelaro R. C., Rushlow K. E. Analysis of equine humoral immune responses to the transmembrane envelope glycoprotein (gp45) of equine infectious anemia virus. J Virol. 1991 Feb;65(2):1013–1018. doi: 10.1128/jvi.65.2.1013-1018.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Clabough D. L., Gebhard D., Flaherty M. T., Whetter L. E., Perry S. T., Coggins L., Fuller F. J. Immune-mediated thrombocytopenia in horses infected with equine infectious anemia virus. J Virol. 1991 Nov;65(11):6242–6251. doi: 10.1128/jvi.65.11.6242-6251.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Coggins L., Norcross N. L. Immunodiffusion reaction in equine infectious anemia. Cornell Vet. 1970 Apr;60(2):330–335. [PubMed] [Google Scholar]
  11. Dewhurst S., Embretson J. E., Anderson D. C., Mullins J. I., Fultz P. N. Sequence analysis and acute pathogenicity of molecularly cloned SIVSMM-PBj14. Nature. 1990 Jun 14;345(6276):636–640. doi: 10.1038/345636a0. [DOI] [PubMed] [Google Scholar]
  12. Fenyö E. M., Morfeldt-Månson L., Chiodi F., Lind B., von Gegerfelt A., Albert J., Olausson E., Asjö B. Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates. J Virol. 1988 Nov;62(11):4414–4419. doi: 10.1128/jvi.62.11.4414-4419.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Fisher A. G., Ensoli B., Looney D., Rose A., Gallo R. C., Saag M. S., Shaw G. M., Hahn B. H., Wong-Staal F. Biologically diverse molecular variants within a single HIV-1 isolate. Nature. 1988 Aug 4;334(6181):444–447. doi: 10.1038/334444a0. [DOI] [PubMed] [Google Scholar]
  14. Gonda M. A., Charman H. P., Walker J. L., Coggins L. Scanning and transmission electron microscopic study of equine infectious anemia virus. Am J Vet Res. 1978 May;39(5):731–740. [PubMed] [Google Scholar]
  15. Goodenow M., Huet T., Saurin W., Kwok S., Sninsky J., Wain-Hobson S. HIV-1 isolates are rapidly evolving quasispecies: evidence for viral mixtures and preferred nucleotide substitutions. J Acquir Immune Defic Syndr. 1989;2(4):344–352. [PubMed] [Google Scholar]
  16. Gutekunst D. E., Becvar C. S. Responses in horses infected with equine infectious anemia virus adapted to tissue culture. Am J Vet Res. 1979 Jul;40(7):974–977. [PubMed] [Google Scholar]
  17. Hussain K. A., Issel C. J., Schnorr K. L., Rwambo P. M., Montelaro R. C. Antigenic analysis of equine infectious anemia virus (EIAV) variants by using monoclonal antibodies: epitopes of glycoprotein gp90 of EIAV stimulate neutralizing antibodies. J Virol. 1987 Oct;61(10):2956–2961. doi: 10.1128/jvi.61.10.2956-2961.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Issel C. J., Coggins L. Equine infectious anemia: current knowledge. J Am Vet Med Assoc. 1979 Apr 1;174(7):727–733. [PubMed] [Google Scholar]
  19. Kawakami T., Sherman L., Dahlberg J., Gazit A., Yaniv A., Tronick S. R., Aaronson S. A. Nucleotide sequence analysis of equine infectious anemia virus proviral DNA. Virology. 1987 Jun;158(2):300–312. doi: 10.1016/0042-6822(87)90202-9. [DOI] [PubMed] [Google Scholar]
  20. Kemeny L. J., Mott L. O., Pearson J. E. Titration of equine infectious anemia virus. Effect of dosage on incubation time and clinical signs. Cornell Vet. 1971 Oct;61(4):687–695. [PubMed] [Google Scholar]
  21. Kim S., Ikeuchi K., Groopman J., Baltimore D. Factors affecting cellular tropism of human immunodeficiency virus. J Virol. 1990 Nov;64(11):5600–5604. doi: 10.1128/jvi.64.11.5600-5604.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Kobayashi K., Kono Y. Propagation and titration of equine infectious anemia virus in horse leukocyte culture. Natl Inst Anim Health Q (Tokyo) 1967 Spring;7(1):8–20. [PubMed] [Google Scholar]
  23. Kono Y., Yoshino T., Fukanaga Y. Growth characteristics of equine infectious anemia virus in horse leukocyte cultures. Brief report. Arch Gesamte Virusforsch. 1970;30(2):252–256. doi: 10.1007/BF01250196. [DOI] [PubMed] [Google Scholar]
  24. Kusumi K., Conway B., Cunningham S., Berson A., Evans C., Iversen A. K., Colvin D., Gallo M. V., Coutre S., Shpaer E. G. Human immunodeficiency virus type 1 envelope gene structure and diversity in vivo and after cocultivation in vitro. J Virol. 1992 Feb;66(2):875–885. doi: 10.1128/jvi.66.2.875-885.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Malmquist W. A., Barnett D., Becvar C. S. Production of equine infectious anemia antigen in a persistently infected cell line. Arch Gesamte Virusforsch. 1973;42(4):361–370. doi: 10.1007/BF01250717. [DOI] [PubMed] [Google Scholar]
  26. Miller M. A., Garry R. F., Jaynes J. M., Montelaro R. C. A structural correlation between lentivirus transmembrane proteins and natural cytolytic peptides. AIDS Res Hum Retroviruses. 1991 Jun;7(6):511–519. doi: 10.1089/aid.1991.7.511. [DOI] [PubMed] [Google Scholar]
  27. Noiman S., Yaniv A., Tsach T., Miki T., Tronick S. R., Gazit A. The Tat protein of equine infectious anemia virus is encoded by at least three types of transcripts. Virology. 1991 Oct;184(2):521–530. doi: 10.1016/0042-6822(91)90422-8. [DOI] [PubMed] [Google Scholar]
  28. Orrego A., Issel C. J., Montelaro R. C., Adams W. V., Jr Virulence and in vitro growth of a cell-adapted strain of equine infectious anemia virus after serial passage in ponies. Am J Vet Res. 1982 Sep;43(9):1556–1560. [PubMed] [Google Scholar]
  29. Payne S. L., Fang F. D., Liu C. P., Dhruva B. R., Rwambo P., Issel C. J., Montelaro R. C. Antigenic variation and lentivirus persistence: variations in envelope gene sequences during EIAV infection resemble changes reported for sequential isolates of HIV. Virology. 1987 Dec;161(2):321–331. doi: 10.1016/0042-6822(87)90124-3. [DOI] [PubMed] [Google Scholar]
  30. Payne S. L., Rushlow K., Dhruva B. R., Issel C. J., Montelaro R. C. Localization of conserved and variable antigenic domains of equine infectious anemia virus envelope glycoproteins using recombinant env-encoded protein fragments produced in Escherichia coli. Virology. 1989 Oct;172(2):609–615. doi: 10.1016/0042-6822(89)90203-1. [DOI] [PubMed] [Google Scholar]
  31. Payne S. L., Salinovich O., Nauman S. M., Issel C. J., Montelaro R. C. Course and extent of variation of equine infectious anemia virus during parallel persistent infections. J Virol. 1987 Apr;61(4):1266–1270. doi: 10.1128/jvi.61.4.1266-1270.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Perryman L. E., O'Rourke K. I., McGuire T. C. Immune responses are required to terminate viremia in equine infectious anemia lentivirus infection. J Virol. 1988 Aug;62(8):3073–3076. doi: 10.1128/jvi.62.8.3073-3076.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Pomerantz R. J., Feinberg M. B., Andino R., Baltimore D. The long terminal repeat is not a major determinant of the cellular tropism of human immunodeficiency virus type 1. J Virol. 1991 Feb;65(2):1041–1045. doi: 10.1128/jvi.65.2.1041-1045.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Rice N. R., Henderson L. E., Sowder R. C., Copeland T. D., Oroszlan S., Edwards J. F. Synthesis and processing of the transmembrane envelope protein of equine infectious anemia virus. J Virol. 1990 Aug;64(8):3770–3778. doi: 10.1128/jvi.64.8.3770-3778.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Rice N. R., Lequarre A. S., Casey J. W., Lahn S., Stephens R. M., Edwards J. Viral DNA in horses infected with equine infectious anemia virus. J Virol. 1989 Dec;63(12):5194–5200. doi: 10.1128/jvi.63.12.5194-5200.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Rushlow K., Olsen K., Stiegler G., Payne S. L., Montelaro R. C., Issel C. J. Lentivirus genomic organization: the complete nucleotide sequence of the env gene region of equine infectious anemia virus. Virology. 1986 Dec;155(2):309–321. doi: 10.1016/0042-6822(86)90195-9. [DOI] [PubMed] [Google Scholar]
  37. Rwambo P. M., Issel C. J., Adams W. V., Jr, Hussain K. A., Miller M., Montelaro R. C. Equine infectious anemia virus (EIAV) humoral responses of recipient ponies and antigenic variation during persistent infection. Arch Virol. 1990;111(3-4):199–212. doi: 10.1007/BF01311054. [DOI] [PubMed] [Google Scholar]
  38. Sakai K., Dewhurst S., Ma X. Y., Volsky D. J. Differences in cytopathogenicity and host cell range among infectious molecular clones of human immunodeficiency virus type 1 simultaneously isolated from an individual. J Virol. 1988 Nov;62(11):4078–4085. doi: 10.1128/jvi.62.11.4078-4085.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Salinovich O., Payne S. L., Montelaro R. C., Hussain K. A., Issel C. J., Schnorr K. L. Rapid emergence of novel antigenic and genetic variants of equine infectious anemia virus during persistent infection. J Virol. 1986 Jan;57(1):71–80. doi: 10.1128/jvi.57.1.71-80.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Saman E., Breugelmans K., Heyndrickx L., Merregaert J. The open reading frame ORF S3 of equine infectious anemia virus is expressed during the viral life cycle. J Virol. 1990 Dec;64(12):6319–6324. doi: 10.1128/jvi.64.12.6319-6324.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Southern P. J., Berg P. Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J Mol Appl Genet. 1982;1(4):327–341. [PubMed] [Google Scholar]
  42. Stephens R. M., Casey J. W., Rice N. R. Equine infectious anemia virus gag and pol genes: relatedness to visna and AIDS virus. Science. 1986 Feb 7;231(4738):589–594. doi: 10.1126/science.3003905. [DOI] [PubMed] [Google Scholar]
  43. Stephens R. M., Derse D., Rice N. R. Cloning and characterization of cDNAs encoding equine infectious anemia virus tat and putative Rev proteins. J Virol. 1990 Aug;64(8):3716–3725. doi: 10.1128/jvi.64.8.3716-3725.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Takeuchi Y., Akutsu M., Murayama K., Shimizu N., Hoshino H. Host range mutant of human immunodeficiency virus type 1: modification of cell tropism by a single point mutation at the neutralization epitope in the env gene. J Virol. 1991 Apr;65(4):1710–1718. doi: 10.1128/jvi.65.4.1710-1718.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Toneguzzo F., Beck J., Cahill P., Ciarkowski M., Page G., Glynn S., Hungerman E., Levi E., Ikeda R., McKenney K. A system for on-line detection and resolution of radiolabeled DNA molecules and its application to automated DNA sequence analysis. Biotechniques. 1989 Sep;7(8):866–877. [PubMed] [Google Scholar]
  46. Vartanian J. P., Meyerhans A., Asjö B., Wain-Hobson S. Selection, recombination, and G----A hypermutation of human immunodeficiency virus type 1 genomes. J Virol. 1991 Apr;65(4):1779–1788. doi: 10.1128/jvi.65.4.1779-1788.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Velpandi A., Nagashunmugam T., Murthy S., Cartas M., Monken C., Srinivasan A. Generation of hybrid human immunodeficiency virus utilizing the cotransfection method and analysis of cellular tropism. J Virol. 1991 Sep;65(9):4847–4852. doi: 10.1128/jvi.65.9.4847-4852.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Whetter L., Archambault D., Perry S., Gazit A., Coggins L., Yaniv A., Clabough D., Dahlberg J., Fuller F., Tronick S. Equine infectious anemia virus derived from a molecular clone persistently infects horses. J Virol. 1990 Dec;64(12):5750–5756. doi: 10.1128/jvi.64.12.5750-5756.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Yaniv A., Dahlberg J., Gazit A., Sherman L., Chiu I. M., Tronick S. R., Aaronson S. A. Molecular cloning and physical characterization of integrated equine infectious anemia virus: molecular and immunologic evidence of its close relationship to ovine and caprine lentiviruses. Virology. 1986 Oct 15;154(1):1–8. doi: 10.1016/0042-6822(86)90424-1. [DOI] [PubMed] [Google Scholar]
  50. York-Higgins D., Cheng-Mayer C., Bauer D., Levy J. A., Dina D. Human immunodeficiency virus type 1 cellular host range, replication, and cytopathicity are linked to the envelope region of the viral genome. J Virol. 1990 Aug;64(8):4016–4020. doi: 10.1128/jvi.64.8.4016-4020.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES